No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Lake Street Maintains Hyperfine(HYPR.US) With Buy Rating, Maintains Target Price $1.5
Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Cullinan Management (CGEM)
Hyperfine Enrolls First Patients in Portable MRI Evaluation Study
Hyperfine Enrolls Initial Patients In NEURO PMR Study
With A 27% Price Drop For Hyperfine, Inc. (NASDAQ:HYPR) You'll Still Get What You Pay For
Lake Street Initiates Hyperfine(HYPR.US) With Buy Rating, Announces Target Price $1.5